Antimicrobial stewardship lessons: do Pseudomonas-sparing agents, such as ertapenem, effectively improve bacterial resistance?
dos Santos
Rodrigo Pires
RP
Jacoby
Thalita
T
Goldani
Luciano Zubaran
LZ
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D015780:Carbapenems / Q000494:pharmacology / Q000627:therapeutic use; D000077727:Ertapenem; D006801:Humans; D015378:Imipenem / Q000494:pharmacology / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D013407:Sulbactam / Q000494:pharmacology / Q000627:therapeutic use; D047090:beta-Lactams / Q000494:pharmacology* / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D047090:beta-Lactams; D015378:Imipenem; D000667:Ampicillin; D000077727:Ertapenem; D013407:Sulbactam